Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
Lancet (London, England)
|
February 26, 2013
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
Mathias J Rummel, Norbert Niederle, Georg Maschmeyer, et al.
Annals of Hematology
|
September 13, 2013
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Sabine Mousset, Dieter Buchheidt, Werner Heinz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2017
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
Marianne Sinn, Marcus Bahra, Torsten Liersch, et al.
The Lancet. Oncology
|
April 2, 2026
Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology
Sibylle C Mellinghoff, Blasius Liss, Jannik Stemler, et al.
Annals of Hematology
|
September 19, 2003
Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Hermann Einsele, Hartmut Bertz, Jörg Beyer, et al.
The Journal of Antimicrobial Chemotherapy
|
February 15, 2008
Risk factors for breakthrough invasive fungal infection during secondary prophylaxis
Oliver A Cornely, Angelika Böhme, Dietmar Reichert, et al.
Reviews in Clinical and Experimental Hematology
|
June 13, 2002
Acute myeloid leukemia: treatment over 60
Thomas Büchner, Wolfgang Hiddemann, Wolfgang Berdel, et al.
Annals of Hematology
|
July 7, 2021
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials
Thomas Heinicke, Rainer Krahl, Christoph Kahl, et al.
Mycoses
|
April 3, 2020
Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Markus Ruhnke, Oliver A Cornely, Martin Schmidt-Hieber, et al.
Annals of Hematology
|
December 9, 2017
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Sibylle C Mellinghoff, Jens Panse, Nael Alakel, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
Lancet (London, England)
|
February 26, 2013
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
Mathias J Rummel, Norbert Niederle, Georg Maschmeyer, et al.
Annals of Hematology
|
September 13, 2013
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Sabine Mousset, Dieter Buchheidt, Werner Heinz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2017
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
Marianne Sinn, Marcus Bahra, Torsten Liersch, et al.
The Lancet. Oncology
|
April 2, 2026
Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology
Sibylle C Mellinghoff, Blasius Liss, Jannik Stemler, et al.
Annals of Hematology
|
September 19, 2003
Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Hermann Einsele, Hartmut Bertz, Jörg Beyer, et al.
The Journal of Antimicrobial Chemotherapy
|
February 15, 2008
Risk factors for breakthrough invasive fungal infection during secondary prophylaxis
Oliver A Cornely, Angelika Böhme, Dietmar Reichert, et al.
Reviews in Clinical and Experimental Hematology
|
June 13, 2002
Acute myeloid leukemia: treatment over 60
Thomas Büchner, Wolfgang Hiddemann, Wolfgang Berdel, et al.
Annals of Hematology
|
July 7, 2021
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials
Thomas Heinicke, Rainer Krahl, Christoph Kahl, et al.
Mycoses
|
April 3, 2020
Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
Markus Ruhnke, Oliver A Cornely, Martin Schmidt-Hieber, et al.
Annals of Hematology
|
December 9, 2017
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Sibylle C Mellinghoff, Jens Panse, Nael Alakel, et al.
Page
of 10